The global perfusion imaging market is on a trajectory of robust growth, with market revenues expected to rise from USD 2,421.4 million in 2024 to nearly USD 3,382.8 million by 2034. According to a ...
CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced it will be presenting next week at Terrapinn’s Advanced Therapies Congress 2025, held in London. Ibon ...
Early invasive management does not reduce the risk of hard clinical outcomes, such as mortality or MI, in women with ...
Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 ...
Jack Shields died last April following a history of heart problems - but a coroner has said that if a paramedic crew had ...
Jamestown Regional Medical Center has earned recognition for its commitment to cardiac care, receiving a one-year provisional ...
Discover Magazine on MSN4d
Contrary to Popular Belief, CPR Is Not as Successful as Many ThinkLearn more about CPR and why this "life-saving" method could actually cause more pain in both patients and medical ...
A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.
Following injury, many organs are capable of rapid regeneration of necrotic tissue to regain normal function. In contrast, ...
IVUS and OCT cited as playing essential and complementary roles, validating Novasight’s unique hybrid imaging capability– Guidelines constitute ...
Maintaining mitochondrial DNA (mtDNA) integrity is crucial for cardiomyocyte function, and its disruption plays a significant role in ischemia/reperfusion (I/R) injury.
A boxed warning for testosterone on major adverse cardiovascular events is out and a new blood pressure warning is in, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback